wanhua(SH:600309) DT新材料·2026-01-16 16:05Core Viewpoint - The strategic cooperation between Wanhua Chemical and Juren New Materials focuses on core raw material supply, quality control, and supply chain optimization to address market fluctuations and quality challenges in the raw material sector [2]. Group 1: Company Overview - Juren New Materials, established in March 2014, is recognized as a national high-tech enterprise and a key leading company in Hunan Province, with multiple rounds of financing from various investors [4]. - The company plans to raise 292 million yuan through an IPO on the Beijing Stock Exchange by June 2025, aimed at funding a 40,000 tons/year special polycaprolactone intelligent chemical plant project and a research center [4]. Group 2: Production Capacity and Achievements - Juren New Materials has become one of the few companies globally capable of industrially producing ε-caprolactone, with its first production line launched in June 2016 [6]. - The company has achieved significant production capacity growth, with ε-caprolactone capacity increasing from 3,500 tons in 2022 to 34,000 tons in 2024 [8]. - In 2023, Juren New Materials successfully trialed a new 50,000 tons/year biodegradable material ε-caprolactone facility, the largest single-unit ε-caprolactone plant globally [6]. Group 3: Market Position and Financial Performance - Juren New Materials holds a 37.21% market share in the domestic ε-caprolactone market as of 2023, making it the largest supplier in this sector [7]. - The company's revenue has shown rapid growth, with figures of 192 million yuan in 2022, 282 million yuan in 2023, and projected 479 million yuan in 2024, alongside net profits increasing from 47.26 million yuan in 2022 to 83.35 million yuan in 2024 [9]. Group 4: Product Applications and Innovations - ε-caprolactone and its derivatives are widely used in various fields, including biodegradable materials, medical applications, and as components in solid-state lithium batteries, showcasing their importance in advanced technology sectors [12]. - The company has developed a range of derivatives from ε-caprolactone, which are utilized in industries such as new energy vehicles, environmental coatings, and biomedical applications [10].